First Trust Advisors’s Intersect ENT, Inc XENT Stock Holding History

First Trust Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-24,443	Closed	-$556K	–	2520
2019 Q2	$556K	Buy	+24,443	New	+$659K	﹤0.01%	2071
2018 Q4	–	Sell	-58,493	Closed	-$1.68M	–	2509
2018 Q3	$1.68M	Sell	58,493 -30,688	-34%	-$922K	﹤0.01%	1755
2018 Q2	$3.34M	Buy	+89,181	New	+$3.5M	0.01%	1327

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

First Trust Advisors's XENT Position: Q3 2019 in Review

First Trust Advisors sold out of Intersect ENT, Inc (XENT) in Q3 2019, closing a stake of 24,443 shares — an estimated $556K sold.

First Trust Advisors first reported a position in XENT in Q2 2018 and held it in 3 quarters. The position peaked at $3.34M in Q2 2018. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2019.

First Trust Advisors reported no remaining Intersect ENT, Inc position as of Q3 2019 after selling out during the quarter.
First Trust Advisors sold 24,443 Intersect ENT, Inc shares in Q3 2019, an estimated $556K.
First Trust Advisors first reported a position in Intersect ENT, Inc in Q2 2018 and held it in 3 quarters.
First Trust Advisors's Intersect ENT, Inc position peaked at $3.34M in Q2 2018.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2019.

Based on First Trust Advisors's 13F filing for Q3 2019, filed 4 Nov 2019.